Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

clinical trialsClinicalTrials.govT1Dtrial matching

What this is and is not

This is a discovery layer for official trial records. It is not an eligibility decision, treatment recommendation, or invitation to share private health information.

A useful trial watch should help a family ask better questions: Who is eligible? What is the intervention? Where is the site? What is the burden? What endpoints are being measured?

Recruiting records to inspect

Diabetes Multimorbidity Typology, Trajectory, and Feasibility of an Audio Diary Mobile Application to Support Self-management — RECRUITING, NA. Interventions: Fabla Mobile App. Locations: Atlanta, Georgia, United States. The goal of this clinical trial is to evaluate whether an audio diary mobile application (Fabla-diabetesMM) is feasible to use...Source
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery — RECRUITING, NA. Interventions: Bionic Pancreas, Routine Care. Locations: Aurora, Colorado, United States | Boston, Massachusetts, United States. The goal of this randomized controlled trial is to compare the efficacy an...Source
Type 1 Diabetes and Diabetes Distress — RECRUITING, NA. Interventions: ACTnow. Locations: Esbjerg, Denmark | Odense, Denmark | Sønderborg, Denmark. The goal of this clinical trial is to reduce diabetes distress in emerging adults (18-35 years) with type 1 dia...Source
Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge — RECRUITING, NA. Interventions: Libre 3 Plus Continuous Glucose Monitor, Dexcom G7 Continuous Glucose Monitor. Locations: Nashville, Tennessee, United States. This study aims to improve patient awareness of the utility o...Source
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes — RECRUITING, PHASE3. Interventions: Semaglutide Pen Injector, Placebo. Locations: Aurora, Colorado, United States | Seattle, Washington, United States. This trial plans to learn more about the effects of a medication, se...Source
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study) — RECRUITING. Interventions: Beta Cell Loss and Immune Function, Immune Function with RNAseq. Locations: Seattle, Washington, United States | Leiden, Leiden, Netherlands | Exeter, Devon, United Kingdom. Type 1 diabetes (T...Source
Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy — RECRUITING, NA. Interventions: Single-session panretinal PRP (SS-PRP), Multiple-session panretinal PRP (MS-PRP). Locations: Mölndal, Sweden. Proliferative diabetic retinopathy (PDR) is the leading cause for blindness in...Source
Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression — RECRUITING, NA. Interventions: Unified protocol for cognitive behavioral therapy (UP-CBT), Continuous Glucose Monitoring (CGM). Locations: Boston, Massachusetts, United States | The Bronx, New York, United States. This...Source

Questions before contacting a study

Is the study specifically for Type 1 diabetes, and does it match the participant age, disease stage, and treatment context?
What travel, visit frequency, labs, devices, medication changes, and hypoglycemia risk are involved?
Can the family discuss the official record with their endocrinology team before sharing additional personal health details?

This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.